Strategy
In order to establish a portfolio of ambitious and competitive products, Affichem:-
will continue its policy of close cooperation with important French and foreign public research organizations;
-
intends to develop in the short-term the various products generated by the discovery of a new cancer biomarker (diagnostic kits, clinical therapeutic monitoring tools, theranostics);
-
will look for strategic alliances at the financial and industrial level in order to secure the clinical development of its projects.